| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.76B | 44.10B | 43.97B | 40.95B | 37.30B | 30.79B |
| Gross Profit | 13.97B | 13.15B | 13.31B | 13.47B | 12.05B | 8.96B |
| EBITDA | 4.29B | 3.01B | 3.97B | 4.13B | 3.19B | 1.06B |
| Net Income | 3.79B | 1.38B | 3.50B | 2.80B | 601.00M | 1.14B |
Balance Sheet | ||||||
| Total Assets | 43.16B | 53.49B | 45.20B | 41.47B | 41.78B | 36.84B |
| Cash, Cash Equivalents and Short-Term Investments | 8.35B | 10.39B | 10.29B | 9.37B | 8.13B | 6.99B |
| Total Debt | 2.49B | 6.62B | 2.75B | 1.41B | 3.12B | 2.87B |
| Total Liabilities | 12.84B | 20.76B | 14.44B | 13.10B | 16.88B | 13.35B |
| Stockholders Equity | 30.32B | 32.73B | 30.76B | 28.37B | 24.89B | 23.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 722.00M | 2.68B | 3.13B | 1.30B | -1.33B |
| Operating Cash Flow | 0.00 | 2.39B | 3.27B | 3.74B | 1.73B | -1.07B |
| Investing Cash Flow | 0.00 | -4.45B | -2.81B | -569.00M | -666.00M | 214.00M |
| Financing Cash Flow | 0.00 | 2.15B | 477.00M | -1.97B | 74.00M | 42.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥28.56B | 6.45 | 14.95% | 0.77% | 1.57% | -2.93% | |
68 Neutral | ¥250.27B | 10.38 | 12.24% | 2.31% | -6.81% | 72.30% | |
68 Neutral | ¥42.88B | 17.96 | ― | 4.43% | -0.53% | -31.86% | |
67 Neutral | ¥42.90B | 7.02 | ― | 2.93% | -1.36% | -9.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥4.14B | 11.96 | ― | 2.01% | 2.87% | 60.30% | |
54 Neutral | ¥36.90B | 26.36 | ― | 2.26% | 0.63% | -60.75% |